Avalyn Pharma Inc. (AVLN): SCHEDULE 13G filed May 7, 2026

Form type
SCHEDULE 13G
Filing date
May 7, 2026
Accession number
0001193125-26-212017
Filer
Avalyn Pharma Inc. (CIK 1540171)